XenoPort Lands $20,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4c87201-9cb9-4efb-be88-7eebb8b6d57a&Preview=1 -
Date
11/20/2012 -
Company Name
XenoPort -
Mailing Address
3410 Central Expressway Santa Clara, CA 95051 -
Company Description
XenoPort, Inc., based in Santa Clara, California, is a privately held biopharmaceutical company focused on harnessing the bodys intrinsic cellular transport systems to improve the oral absorption, distribution and pharmacokinetics of drugs. -
Website
http://www.xenoport.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
